HLTT — Healthtech Solutions Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
- $0.01m
- $2.58m
- $1.69m
Annual income statement for Healthtech Solutions, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2009 December 31st | 2010 December 31st | 2020 June 30th | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.63 | 8.15 | 0 | 0 | 1.69 |
Cost of Revenue | |||||
Gross Profit | 2.75 | 2.49 | — | — | 1.56 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 7.24 | 6.81 | 0.037 | 5.01 | 5.14 |
Operating Profit | 1.39 | 1.34 | -0.037 | -5.01 | -3.46 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.37 | 1.2 | -0.037 | -8.31 | -3.46 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.19 | 1.04 | -0.037 | -8.31 | -3.46 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1.05 | 0.932 | -0.037 | -9.11 | -3.04 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1.05 | 0.932 | -0.037 | -9.11 | -3.04 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.054 | 0.048 | -0.004 | -0.282 | -0.045 |
Dividends per Share |